Navigation Links
Martek Announces Fourth Quarter and FY 2009 Financial Results
Date:12/16/2009

rily to certain previously unrecognized income tax credits

Investor Conference Call Webcast

Martek will host a conference call and Webcast for investors to review its fourth quarter results and fiscal 2010 outlook at 4:45 p.m. Eastern Time on Wednesday, December 16, 2009. Access to the live audio Webcast is available through Martek's website at http://investors.martek.com. The webcast will be available for replay through the close of business on January 16, 2010.

General

Sections of this release contain forward-looking statements concerning, among other things: (1) Martek's expectations regarding future revenue growth in and customer demand from the infant formula, pregnancy and nursing, nutritional supplements, animal feeds and food and beverage markets; (2) its expectations regarding customer stocking or de-stocking of inventory; (3) its expectations regarding revenue, gross margin, operating expenses and income for the first quarter of and full fiscal year 2010; (4) its expectations regarding launches by customers of products containing Martek's life'sDHA(TM) and future revenues associated with Martek's contract manufacturing and collaborative services with BP; and (5) possible acquisition activities. Furthermore, Martek's operating results are subject to quarter-to-quarter fluctuations, some of which may be significant. The forward-looking statements noted above are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors and cautionary statements set forth herein and in the Company's filings with the Securities and Exchange C
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Martek Signs Sole-Source Supply Agreement with Fonterra
2. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
3. Martek Announces Addition to Its Board of Directors
4. Martek to Present at Two Upcoming Investor Conferences
5. Martek Announces Settlement of Patent Dispute with Capsugel France
6. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
7. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
8. Martek to Announce Third Quarter 2009 Results
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
11. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... PARK, N.C. , Aug. 27, 2015 /PRNewswire/ ... the decision by FedEx, UPS and The US ... certain biological specimens classified as ,select agents, by ... long history of handling these sensitive shipments. ... of global transportation regulations, trained and certified personnel ...
(Date:8/26/2015)...  Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... for the detection of foodborne pathogens, today announced that ... & Company Emerging Growth Conference on September 2 at ... New York Marriott Marquis. A live ... investor relations section of Roka Bioscience,s website at ...
(Date:8/26/2015)... GERMANTOWN, Md. , Aug. 26, 2015 ... synthetic biology, announced today the closing of its previously ... in full by the underwriters of their option to ... the public offering price of $41.00 per share.  The ... of shares of common stock sold by Intrexon to ...
(Date:8/26/2015)... Florida , August 26, 2015 ... the biggest factors fueling the optimism in biotech,s ... M&A,s, collaborations and life sciences advancements.  Active biotechnology ... are Pressure BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. ... SRPT ), Raptor Pharmaceutical Corp. (NASDAQ: ...
Breaking Biology Technology:Marken Ensures Safe Transportation Of Select Agents And Toxins 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... CHICAGO, March 9, 2011 GlobalCare Clinical Trials, ... America. GlobalCare provides selected clinical study visits at ... or alternate settings – for study patients to ... therapeutic areas, genomics and personalized medicine in all ...
... BEIJING, March 9, 2011 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: ... agricultural nutrient company in China, today announced that the Company ... on Tuesday, March 15, 2011, to discuss its fourth quarter ... in the live conference call, please dial the following number ...
... March 9, 2011 AccessClosure, Inc., the U.S. ... today results from the first published study* (Journal ... deployment of different vascular closure devices (VCD) as ... trial compared the discomfort associated with the Mynx ...
Cached Biology Technology:GlobalCare Clinical Trials, Ltd Announces Company Expansion Into Latin America 2GlobalCare Clinical Trials, Ltd Announces Company Expansion Into Latin America 3GlobalCare Clinical Trials, Ltd Announces Company Expansion Into Latin America 4Yongye International Announces Conference Call to Discuss Fourth Quarter and Full Year 2010 Results 2Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device 2Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device 3
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, ... expected revenues in 2015 that relate to sales of FPC1155 for ... approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO of ... smartphone manufacturer in China and ... 155 for Z1 , ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/5/2015)... , August 5, 2015 According ... Access Management Market by Software, Services, Vertical (BFSI, Airport, IT ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... Market globally into various segments. The global PIAM Market ... to $546.2 Million by 2019, at a CAGR of ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... with optics for processing data in computers is coming ... properties of fast and slow light. The long term ... densities by several orders of magnitude and take the ... improved performance with dramatically lower energy consumption. , The ...
... first experiment involving a natural environment, scientists at ... significantly enhances an ecosystem,s productivity. The finding underscores ... dioxide, a main contributor to global warming. ... and the Sloan Lindeman Professor of Biology at ...
... Centre for Addiction and Mental Health (CAMH) has ... mental retardation (MR) along with the eye defect ... unidentified gene that causes this disorder, CC2D2A. ... and biological processes involved in brain development, and ...
Cached Biology News:European light research opens door for optical storage and computing 2Brown scientists say biodiversity is crucial to ecosystem productivity 2New gene discovered for new form of intellectual disability 2
... 2500ml narrow mouth PYREX low form culture flask is ... to volume ratio. This flask has a heavy beaded ... marking spot. The neck O.D. is 38mm and takes ... use this flask on a heat source smaller than ...
... is designed to allow ampicillin selection in ... driving the gene for ampicillin resistance is ... promoter. It mediates higher transcription efficiency than ... polyadenylation signal terminates the ampicillin expression. The ...
... Pyronin Y is most widely used ... selectively and differentially stain nucleic acids ... dichromatic dye solution, Pyronin Y stains ... DNA green. Chem comp: ...
... a magnetic bead-based PCR purification ... transfer, centrifugation or filtration steps. ... large PCR extension products in ... AMPure can easily be performed ...
Biology Products: